Showing results (1-10 of 606) with videos related to

Sort By:
Pageof 61
Journal of Gastroenterology|January 31, 2020
Recent advances in chemotherapy for pancreatic cancer: evidence from Japan and recommendations in guidelinesTakuji Okusaka, Junji Furuse
Cancers|November 12, 2013
Targeted therapy for biliary tract cancerJunji Furuse, Takuji Okusaka
Japanese Journal of Clinical Oncology|October 27, 2012
The Hepatobiliary and Pancreatic Oncology (HBPO) Group of the Japan Clinical Oncology Group (JCOG): history and future directionJunji Furuse, Hiroshi Ishii, Takuji Okusaka
Japanese Journal of Clinical Oncology|July 28, 2006
A phase I/II study of combination chemotherapy with gemcitabine and 5-fluorouracil for advanced pancreatic cancerTakuji Okusaka, Hiroshi Ishii, Akihiro Funakoshi, et al.
Japanese Journal of Clinical Oncology|December 19, 2017
Chemotherapy for hepatocellular carcinoma: current status and future perspectivesMasafumi Ikeda, Chigusa Morizane, Makoto Ueno, et al.
Japanese Journal of Clinical Oncology|February 4, 2025
Update for: New developments in systemic therapy for advanced biliary tract cancerChigusa Morizane, Makoto Ueno, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology|July 19, 2005
A phase II trial of Uracil-tegafur (UFT) in patients with advanced biliary tract carcinomaMasafumi Ikeda, Takuji Okusaka, Hideki Ueno, et al.
Japanese Journal of Clinical Oncology|December 12, 2019
A review of changes to and clinical implications of the eighth TNM classification of hepatobiliary and pancreatic cancersMakoto Ueno, Chigusa Morizane, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology|June 13, 2018
New developments in systemic therapy for advanced biliary tract cancerChigusa Morizane, Makoto Ueno, Masafumi Ikeda, et al.
Japanese Journal of Clinical Oncology|February 3, 2025
Systemic therapy for hepatocellular carcinoma, from the early to the advanced stage: a Japanese perspectiveMasafumi Ikeda, Chigusa Morizane, Makoto Ueno, et al.
Pageof 61